These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10374439)

  • 1. [Improvements in the treatment and management of control the occurrence of multidrug-resistance tuberculosis].
    Ming A
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):323-4. PubMed ID: 10374439
    [No Abstract]   [Full Text] [Related]  

  • 2. Finding gold in the muddy waters of public health reports.
    Sbarbaro JA
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):689-90. PubMed ID: 15182137
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing drug-resistant tuberculosis with a fixed dose combination of isoniazid and rifampin.
    Moulding TS; Le HQ; Rikleen D; Davidson P
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):743-8. PubMed ID: 15182145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ; Kwon OJ; Park YK; Lew WJ; Bai GH
    Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740
    [No Abstract]   [Full Text] [Related]  

  • 5. Tuberculosis treatment: dangerous regimens?
    Rieder HL; Arnadottir T; Trébucq A; Enarson DA
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis.
    Garner P; Holmes A; Ziganshina L
    Clin Evid; 2004 Jun; (11):1081-93. PubMed ID: 15652053
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuberculosis.
    Garner P; Holmes A; Ziganshina L
    Clin Evid; 2005 Dec; (14):1026-37. PubMed ID: 16620446
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
    Ani AE; Idoko J; Dalyop YB; Pitmang SL
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faulty prescription--an avoidable cause of multidrug resistance tuberculosis.
    Jain RF
    J Indian Med Assoc; 1996 Oct; 94(10):385-8. PubMed ID: 9141879
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Multidrug'-resistant tuberculosis. It is time to focus on the private sector of medicine.
    Sbarbaro JA
    Chest; 1997 May; 111(5):1149-51. PubMed ID: 9149557
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
    Long R; Scalcini M
    Int J Tuberc Lung Dis; 1999 Sep; 3(9):747-8. PubMed ID: 10488879
    [No Abstract]   [Full Text] [Related]  

  • 19. [Duration of the treatment of tuberculosis in 1981].
    Sors C; Dautzenberg B; Grosset J
    Nouv Presse Med; 1982 Mar; 11(11):831. PubMed ID: 7070974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.